Thomson Reuters offers tools and solutions to help clients develop the best benefit plan design for their covered population. We model the effects of plan design on benefit quality, cost, satisfaction, and financial contribution levels for employees and the employer.
Benefits
- Model the effect of changes in co-pays, premiums, enrollment thresholds, and use of generic incentives and mail-order pharmaceutical programs on benefit quality, cost, satisfaction, and financial contribution for employees and their employers.
- Discover reasons for enrollee plan switching, and develop incentives to stimulate use of generic drugs and higher quality providers.
- Our data resources allow clients to develop plans options customized to their covered populations.
-
Advantage Suite - Employers
Advantage Suite® integrates information from diverse sources and systems, organizes it to support decision making, and enables easy access to information in a flexible, customized application. Its powerful applications are linked to an integrated warehouse of medical and prescription claims, encounters, eligibility, lab results, authorizations, health risks assessments, and performance measures. -
Benefit Design Modeler - Employers
As healthcare costs rise, employers struggle to manage employee healthcare benefits. Keeping healthcare accessible and affordable while balancing the overall cost to both employer and employee is a challenge requiring creativity and a firm grasp on the financial impact of plan design changes.
-
Consulting Services - Employers
Our analytic consulting services help you identify and implement the best course of action to achieve your healthcare program objectives. We help you study an isolated cost and quality-related issue – or conduct a more in-depth analysis of inter-related organizational challenges.
-
Risk Profiler
Risk Profiler from the Healthcare business of Thomson Reuters is a one-time analysis and report package that enables organizations to achieve immediate results by identifying opportunities to significantly reduce healthcare risks and costs during the coming fiscal year.